DE29603070U1 - Algae-based remedies for bath therapy - Google Patents
Algae-based remedies for bath therapyInfo
- Publication number
- DE29603070U1 DE29603070U1 DE29603070U DE29603070U DE29603070U1 DE 29603070 U1 DE29603070 U1 DE 29603070U1 DE 29603070 U DE29603070 U DE 29603070U DE 29603070 U DE29603070 U DE 29603070U DE 29603070 U1 DE29603070 U1 DE 29603070U1
- Authority
- DE
- Germany
- Prior art keywords
- algae
- biomass
- protection
- bath therapy
- remedies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000195493 Cryptophyta Species 0.000 title claims description 19
- 238000002560 therapeutic procedure Methods 0.000 title claims description 6
- 239000002028 Biomass Substances 0.000 claims description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 3
- 229940126601 medicinal product Drugs 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 2
- 241000192700 Cyanobacteria Species 0.000 claims 2
- 241000199914 Dinophyceae Species 0.000 claims 2
- 241000195623 Euglenida Species 0.000 claims 2
- 241000224472 Eustigmatophyceae Species 0.000 claims 2
- 241000206759 Haptophyceae Species 0.000 claims 2
- 241000206572 Rhodophyta Species 0.000 claims 2
- 241001467606 Bacillariophyceae Species 0.000 claims 1
- 241000923152 Charophyceae Species 0.000 claims 1
- 241000196319 Chlorophyceae Species 0.000 claims 1
- 241000206751 Chrysophyceae Species 0.000 claims 1
- 241000199919 Phaeophyceae Species 0.000 claims 1
- 241001518925 Raphidophyceae Species 0.000 claims 1
- 241000206764 Xanthophyceae Species 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 239000011785 micronutrient Substances 0.000 claims 1
- 235000013369 micronutrients Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 241000196307 prasinophytes Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000037213 diet Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 235000016425 Arthrospira platensis Nutrition 0.000 description 2
- 240000002900 Arthrospira platensis Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 229940082787 spirulina Drugs 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241000195634 Dunaliella Species 0.000 description 1
- 241000195633 Dunaliella salina Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000008394 flocculating agent Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229920000876 geopolymer Polymers 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 235000019679 nutrient-rich food Nutrition 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical group O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 108010027322 single cell proteins Proteins 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Description
♦omhelttechiiik gmbh ♦omhelttechiiik gmbh
tuowiesTR. 61231 BADKAUHEiM tuowiesTR. 61231 BADKAUHEiM
Einzellige Grün- und Blaualgen wie Spirulina, Chlorella und Dunaliella stellen das bei weitern nährstoffreichste Lebensmittel dar (Kay 1991, Crit. Rev. Food Sei. Nutr. 30, 555). Wegen ihres hohen Energiewertes werden sie deshalb bereits seit längerem bei der Therapie von Ernährungsstörungen und Mangelsyndromen eingesetzt (FlCA et al. 1984, Rev. Med. Int. Med. Int. 36, 225). Seit einiger Zeit werden sie zunehmend als kommerziell bedeutsame Quellen für hochwertiges Eiweiß, sog. "single cell protein" (CHlBA SHOYU 1980, J. Jpn. Soy Sauce Res. Inst. 6, 92), für Vitamine wie Ascorbinsäure, Tocopherol und Carotinoide (Klausner 1986, Biol. Technology 4, 947), für Glyko- und Sulfolipide (Kataoka und MlSAKl 1983, Agr. Biol. Chem. 47, 2349) sowie als Rohstoff für verschiedenste geschmacksneutrale Lebensmittelzusätze und -farbstoffe angesehen.Single-celled green and blue algae such as spirulina, chlorella and dunaliella are by far the most nutrient-rich foods (Kay 1991, Crit. Rev. Food Sei. Nutr. 30, 555). Because of their high energy value, they have long been used in the treatment of nutritional disorders and deficiency syndromes (FlCA et al. 1984, Rev. Med. Int. Med. Int. 36, 225). For some time now they have been increasingly regarded as commercially important sources of high-quality protein, so-called "single cell protein" (CHlBA SHOYU 1980, J. Jpn. Soy Sauce Res. Inst. 6, 92), of vitamins such as ascorbic acid, tocopherol and carotenoids (Klausner 1986, Biol. Technology 4, 947), of glyco- and sulfolipids (Kataoka and MlSAKl 1983, Agr. Biol. Chem. 47, 2349) and as raw materials for a wide variety of taste-neutral food additives and colorants.
Das therapeutische Potential der Mikroalgen erhöht sich dadurch noch weiter, daß seit einiger Zeit zahlreiche positive Effekte von Algendiäten auf die Gesundheit von Mensch und Tier beschrieben worden sind. Hierzu gehört in erster Linie die prophylaktische Wirkung einer Algendiät bei Krebsleiden. Experimentell auslösbare Krebsformen des Rachenraums (Schwartz et al. 1988, Nutr. Cancer 11, 127 sowie SCHWARTZ und SHKLAR 1987, J. Oral Maxillofac. Surg. 45, 510) konnten ebenso wie die spontane Genese des Mammakarzinoms (Nagasawa et al. 1989, Anticancer Res. 9, 71 sowie Combs et al. 1989 Nutr. Cancer 12, 371) mit Spirulina- und Di/na//e//a-Extrakten unterdrückt werden. Berichte über eine radio-protektive Wirkung wäßriger Algenextrakte (Rotkovska et al. 1989, Strahlenther. Onkol. 165. 813; VACEK et al. 1990, Exp. Haematol. 18, 237; QiSHEN et al. 1989, Toxicology Lett. 48, 165) könnten in diesem Zusammenhang mit den extrem hohen Carotingehalten der Algen (bis zu 10 % der Biotrockenmasse, siehe Ben-Amotz und Avron 1983, Plant Physiol. 72, 593) erklärt werden. Bei einigen Formen der Hypercholesterolämie wirkt sich die Supplementierung der Nahrung mit Mikroalgen ebenfalls positiv aus (DEVI und VENKATARAMAN 1983, Nutr. Rep. Int. 28, 519; SANO et al. 1988, Arten/15, 217; NAKAYA et al. 1988, Nutr. Rep. Int. 37, 1329). So konnte u.a. eine experimentell ausgelöste Atherosklerose bei mit Cholesterin gefütterten Ka-The therapeutic potential of microalgae is further increased by the fact that numerous positive effects of algae diets on the health of humans and animals have been described for some time. These include, first and foremost, the prophylactic effect of an algae diet on cancer. Experimentally induced forms of cancer of the throat (Schwartz et al. 1988, Nutr. Cancer 11, 127 and SCHWARTZ and SHKLAR 1987, J. Oral Maxillofac. Surg. 45, 510) as well as the spontaneous genesis of breast cancer (Nagasawa et al. 1989, Anticancer Res. 9, 71 and Combs et al. 1989 Nutr. Cancer 12, 371) could be suppressed with spirulina and di-naphthalene extracts. Reports on a radio-protective effect of aqueous algal extracts (Rotkovska et al. 1989, Strahlenther. Onkol. 165 . 813; VACEK et al. 1990, Exp. Haematol. 18, 237; QiSHEN et al. 1989, Toxicology Lett. 48, 165) could be explained in this context by the extremely high carotene contents of the algae (up to 10 % of the dry biomass, see Ben-Amotz and Avron 1983, Plant Physiol. 72, 593). In some forms of hypercholesterolemia, supplementation of the diet with microalgae also has a positive effect (DEVI and VENKATARAMAN 1983, Nutr. Rep. Int. 28, 519; SANO et al. 1988, Arten/15, 217; NAKAYA et al. 1988, Nutr. Rep. Int. 37, 1329). For example, experimentally induced atherosclerosis in cholesterol-fed cats could be prevented.
-fs-fs
ninchen durch getrocknete, pulverisierte Präparate von Mikroalgen reduziert werden. Letzlich werden auch bei gastrointestinaien Beschwerden und Verdauungstörungen (JASSBY 1988, Algae and Human Affairs, Cambridge University Press, BECKER 1986, Handbook of Microalgal Mass Culture, CRC Press) sowie bei viralen Infektionskrankheiten (GUSTAVSON et al. 1989, J. Nail. Cancer Inst. 8J., 1254) Mikroalgen-Diäten empfohlen.ninchen can be reduced by dried, powdered preparations of microalgae. Finally, microalgae diets are also recommended for gastrointestinal complaints and digestive disorders (JASSBY 1988, Algae and Human Affairs, Cambridge University Press, BECKER 1986, Handbook of Microalgal Mass Culture, CRC Press) as well as for viral infectious diseases (GUSTAVSON et al. 1989, J. Nail. Cancer Inst. 8J., 1254).
Erste pharmazeutische Produkte, die die probiotischen Eigenschaften der Algen nutzen, existieren bereits in Form von Kapseln, Tabletten und Suspensionen. So haben die Patente JP 88-40756 bzw. JP 88-40753 des japanischen Wissenschaftlers TANAKA die gaienische Zubereitung von Algenzeiimassen für ein sog. "functional food" (O'BRIEN 1992, Trends Food Sei. Technol. 3,127) zum Inhalt. Hierbei wird die Algenbiomasse an Cyclodextrin gebunden.The first pharmaceutical products that use the probiotic properties of algae already exist in the form of capsules, tablets and suspensions. For example, the patents JP 88-40756 and JP 88-40753 of the Japanese scientist TANAKA cover the genetic preparation of algae masses for a so-called "functional food" (O'BRIEN 1992, Trends Food Sci. Technol. 3,127). The algae biomass is bound to cyclodextrin.
Die neuartigen Heilmittel, deren Schutz hiermit beantragt wurde, erlauben erstmals die gezielte Nutzung von Algen zur therapie und Prophylaxe von Krankheiten, Gesundheits- bzw. Wohlbefindiichkeitsstörungen speziell in der Balneo- und thalassotherapie (inci. Heimbadekuren).The new medicinal products, the protection of which has been applied for here, allow for the first time the targeted use of algae for the treatment and prophylaxis of diseases, health and well-being disorders, especially in balneotherapy and thalassotherapy (including home spa treatments).
Derartige Anwendungen können aufgrund schulmedizinischer, naturheilkundlicher, diätetischer oder kosmetischer Überlegungen begründet sein.Such applications can be based on conventional medical, naturopathic, dietary or cosmetic considerations.
Die algenhaitigen Präparate können hierbei sowohl innerlich, z.B. als Trinkkur, oder äußerlich, z.B. in Form von Einreibungen, Bädern und Packungen ("synthetische" Heilschlämme) lokal, systemisch oder in Kombination appliziert werden.The algae-containing preparations can be applied either internally, e.g. as a drinking cure, or externally, e.g. in the form of rubs, baths and packs ("synthetic" healing mud), locally, systemically or in combination.
Die Balneo- und Thalassotherapie bei dermatologischen und Herz-Kreislauf-Indikationen wird aufgrund der immer lauter werdende Forderung nach einem zweifelsfreien wissenschaftlichen Nachweis der Wirksamkeit seiner Behandlungsformen bzw. Therapieansätze zunehmend medizinisch in Frage gestellt. Angesichts dieser Situation ist die Nachfrage nach derartigen Therapieansätzen stetig gesunken. Lediglich die Entwicklung innovativer Therapeutika, deren medizinischer Wert wissenschaftlich belegt werden kann, werden zukünftig die Wirksamkeit und somit die Attraktivität von Badekuren und Balneo- und Thalassotherapien nachweislich erhöhen.Balneotherapy and thalassotherapy for dermatological and cardiovascular indications are increasingly being questioned from a medical perspective due to the ever louder demand for unequivocal scientific proof of the effectiveness of its treatment methods and therapeutic approaches. In view of this situation, the demand for such therapeutic approaches has steadily decreased. Only the development of innovative therapeutic agents whose medical value can be scientifically proven will demonstrably increase the effectiveness and thus the attractiveness of spa treatments and balneotherapy and thalassotherapy in the future.
Die in Schutzanspruch 1 mit den dazugehörigen Unteransprüchen beschriebenen neuartigen Heilmittel für die Bädertherapie erfüllen diese Anforderungen.The novel medicinal products for bath therapy described in claim 1 and the associated subclaims meet these requirements.
Das Novum unseres Produktes für die Balneo- und Thalassotherapie besteht darin, daß sich sein therapeutischer Wert aufgrund einer ganzheitlich orientierten und wohldurchdachten Integration von Algenbiomasse in die herkömmlichen Produkte und Verfahren der Bädertherapie von dem der konventionellen Heilmittel (Heilwässer, Badesolen etc.) abhebt:The novelty of our product for balneotherapy and thalassotherapy is that its therapeutic value differs from that of conventional remedies (medicinal waters, bathing brines, etc.) due to a holistically oriented and well-considered integration of algae biomass into the conventional products and procedures of bath therapy:
1. Durch die Kombination von natürlichen Heilsalzen und Algenwirkstoffen wird das Wirkprofil beider Komponenten in synergistischer Weise verstärkt.1. By combining natural healing salts and algae active ingredients, the active profile of both components is enhanced in a synergistic manner.
2. Durch die Immobilisierung der Algenbiomasse an therapeutisch wertvollen Bio- und Geopolymeren wird ihr medizinischer Wert je nach Art des verwendeten Flokkulans für verschiedene Anwendungsgebiete in spezifischer und synergistischer Weise erhöht. Hierbei spielen nicht nur pharmakologische, sondern insbesondere im Falle von Abreibungen und Packungen- auch mechanische Aspekte eine Rolle (z.B. sanfte Abriebeffekte durch feinverteilte Mineralien).2. By immobilizing the algae biomass on therapeutically valuable bio- and geopolymers, their medical value is increased in a specific and synergistic way for different areas of application, depending on the type of flocculant used. Not only pharmacological aspects play a role here, but also mechanical aspects, especially in the case of rubbings and packs (e.g. gentle abrasion effects due to finely distributed minerals).
Durch die Verwendung natürlicher und abbaubarer Flokkulantien oder Adsorbentien entstehen keine Entsorgungsprobleme, so daß unsere Präparate ökologisch völlig unbedenklich sind.By using natural and degradable flocculants or adsorbents, there are no disposal problems, so our preparations are completely ecologically harmless.
Die genannten Unteransprüche beziehen sich auf die unterschiedlichen Möglichkeiten der Ausgestaltung unserer Erfindung.The subclaims mentioned relate to the different possibilities of designing our invention.
So z.B. werden zur Behandlung von Schuppenflechte (Psoriasis) in der Sole einer Heilquelle, welche aufgrund ihres starken Mineralsalzgehaltes bereits in natürlicher Form (z.B. bei der Balneo-Photo-Therapie) als Therapeutikum eingesetzt wird, zusätzlich extrem halophile Grünalgen, wie Dunaliella salina angezogen und nachfolgend mit feinkörnigem Quarzmehl bzw. Kieselsäure versetzt. Dieses Heilmittel wird anschließend in Form von Abreibungen oder eines Heilbades auf den erkrankten Hautpartien lokal appiiziert. Aufgrund des hohen Glyceringehaltes der Alge und der abrasiven Wirkung des Minerals wird der therapeutische Effekt der Heilsole somit in syergistischer Weise verstärkt (sog. Baineo-Phyco-Therapie).For example, to treat psoriasis, extremely halophilic green algae such as Dunaliella salina are grown in the brine of a healing spring, which is already used as a therapeutic agent in its natural form (e.g. in balneo-phototherapy) due to its high mineral salt content, and then mixed with fine-grained quartz powder or silica. This remedy is then applied locally to the affected areas of skin in the form of rubdowns or a healing bath. Due to the high glycerine content of the algae and the abrasive effect of the mineral, the therapeutic effect of the healing brine is thus enhanced in a synergistic manner (so-called baineo-phyco-therapy).
Im Falle einer begleitenden Phototherapie sorgt die photosynthetische Wirkung lebend ausflokkuiierter Algen lokal für eine wesentlich verbesserte Sauerstoffversorgung der Haut, was u.U. die Penetration der Wirksubstanzen noch erhöht (sog. Balneo-Phycoxy-Therapie).In the case of accompanying phototherapy, the photosynthetic effect of living flocculated algae ensures a significantly improved local oxygen supply to the skin, which may further increase the penetration of the active substances (so-called balneo-phycoxy therapy).
GEOLOGISCHE BERATUNGGEOLOGICAL CONSULTING
+UMWELTTECHNIK GMBH+ENVIRONMENTAL TECHNOLOGY GMBH
LUDWIGSTR, 20LUDWIGSTR, 20
61231 BAONAUHEiM61231 BAONAUHEIM
06032 /7285506032 /72855
Claims (2)
dadurch gekennzeichnet,1. Remedies for bath therapy
characterized,
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE29603070U DE29603070U1 (en) | 1996-02-21 | 1996-02-21 | Algae-based remedies for bath therapy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE29603070U DE29603070U1 (en) | 1996-02-21 | 1996-02-21 | Algae-based remedies for bath therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE29603070U1 true DE29603070U1 (en) | 1996-09-19 |
Family
ID=8019817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE29603070U Expired - Lifetime DE29603070U1 (en) | 1996-02-21 | 1996-02-21 | Algae-based remedies for bath therapy |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE29603070U1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2881952A1 (en) * | 2005-02-15 | 2006-08-18 | Daniel Jouvance Rech S Et Crea | Composition containing algae, useful in cosmetics e.g. for skin care to increase the skin firmness, comprises an algae culture of Symbiodinium sp of gymnodinium family or a paste of the algae obtained from the culture |
| CN111467282A (en) * | 2020-04-20 | 2020-07-31 | 李湘宁 | Bath barrel, bathing agent, and preparation method and application thereof |
-
1996
- 1996-02-21 DE DE29603070U patent/DE29603070U1/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2881952A1 (en) * | 2005-02-15 | 2006-08-18 | Daniel Jouvance Rech S Et Crea | Composition containing algae, useful in cosmetics e.g. for skin care to increase the skin firmness, comprises an algae culture of Symbiodinium sp of gymnodinium family or a paste of the algae obtained from the culture |
| CN111467282A (en) * | 2020-04-20 | 2020-07-31 | 李湘宁 | Bath barrel, bathing agent, and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1480661B1 (en) | Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics | |
| EP0796080A1 (en) | Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss | |
| JPH1036283A (en) | Fibroblast proliferation promoting agent | |
| DE19541735A1 (en) | Use of hydrothermal rock deposits e.g. calcite precursors | |
| DE102006056454A1 (en) | Taste-free, granular nutritional supplement, useful e.g. for preventing osteoporosis and psoriasis, contains synergistic combination of Spirulina, Chlorella and Lithothamnium algae | |
| DE19608563A1 (en) | Preparation for oral delivery of pharmaceutical or nourishing materials | |
| KR102367528B1 (en) | Cosmetic composition comprising seaweed extracts | |
| DE2834893C2 (en) | ||
| DE29603070U1 (en) | Algae-based remedies for bath therapy | |
| DE202015106158U1 (en) | Garlic paste | |
| DE60124516T3 (en) | COMBINATION OF THE LEZITHINE WITH ASCORBIC ACID | |
| DE102005020467A1 (en) | Agent for the therapy and prophylaxis of skin diseases | |
| CN103932941A (en) | Nutritional element aging resistant skin-care lotion | |
| JPH104953A (en) | Composition for beauty and health utilizing melatonin yeast | |
| JPH09301884A (en) | Testosterone 5 alpha-reductase inhibitor containing blackberry lily extract and alpha-hydroxyl acid and its application | |
| DE102009052808A1 (en) | Ointment, useful e.g. for treating salt deficiency, acute and chronic trauma, comprises ointment base and homeopathically diluted mineral salt including e.g. calcium phosphate, iron phosphate, potassium chloride and potassium phosphate | |
| DE4022288A1 (en) | MEDIUM AND METHOD FOR STIMULATING GROWTH AND REGENERATION OF HAIR AND NAILS | |
| DE102006054653A1 (en) | Body or beauty care products | |
| JP3563327B2 (en) | Antibacterial and preservatives | |
| LU500687B1 (en) | NUTRITIONAL OR DIETICAL COMPOSITION | |
| CN1079649C (en) | Nutrient concurrently used as medicated diet and cosmetics for preventing and curing hypersensitive stain, senility and obesity and its manufacture method | |
| DE2004409A1 (en) | Natural active ingredient for pharmaceutical and dietetic purposes | |
| EP4248956A2 (en) | Pharmaceutical composition comprising cannabidiol | |
| DE102004010690A1 (en) | Compositions comprising terrestrial mushroom biomass and thiocyanates, e.g. useful as drug carriers, health-promoting products, foods, animal feeds, dietary supplements | |
| WO2016009021A1 (en) | Dosage form containing fungal components |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R207 | Utility model specification |
Effective date: 19961031 |
|
| R156 | Lapse of ip right after 3 years |
Effective date: 20000301 |